Beclomethasone Shortage Update: What Patients Need to Know in 2026

If you use Beclomethasone (Qvar RediHaler) to manage your asthma, you may have noticed it's been harder to find at pharmacies over the past year. So what's the official status — and more importantly, what does it mean for you?

Is There an Official Beclomethasone Shortage in 2026?

As of 2026, Qvar RediHaler (Beclomethasone Dipropionate HFA) is NOT listed on the FDA's official drug shortage database. That is the official government position. However, that doesn't tell the whole story.

Patients across the country have been reporting intermittent difficulty finding Qvar RediHaler at their local pharmacies since late 2024, continuing into 2026. These pharmacy-level stock-outs are real — even when the FDA hasn't formally declared a shortage. The distinction matters for policy, but for a patient who can't fill their prescription today, the effect is the same.

What Is Causing the Supply Problems?

Several factors are driving availability issues for Beclomethasone:

Single manufacturer, no generic. Qvar RediHaler is made only by Teva Pharmaceuticals. Device patents don't expire until approximately May 2031. Any production or distribution issue affects the entire national supply.

Demand surge from ICS market disruptions. When GSK discontinued brand-name Flovent (fluticasone) inhalers in January 2024, and when budesonide (Pulmicort) inhalation suspension went into shortage, many patients and prescribers turned to Qvar as an alternative. This surge in demand has put persistent pressure on Teva's supply.

Complex inhaler manufacturing. The Qvar RediHaler is a breath-actuated metered-dose inhaler — a sophisticated device that requires specialized manufacturing equipment and strict quality control. Production can't be scaled up rapidly.

Uneven distribution. Some pharmacies and regions have stock while others don't. This uneven distribution creates a perception of a widespread shortage even when total national supply is technically adequate.

A Brief Timeline of Beclomethasone Availability Issues

2023: GSK announced plans to discontinue brand-name Flovent inhalers; prescribers begin exploring alternatives including Qvar.

January 2024: Flovent brand officially discontinued; surge in prescriptions for alternative ICS products begins.

2024-2025: Budesonide inhalation suspension enters active shortage; further redirects demand to Qvar. Patient reports of Qvar stock-outs begin increasing.

2026: Qvar remains off the FDA shortage list, but pharmacy-level stock-outs persist. No generic is expected until 2031.

What Can Patients Do Right Now?

Use medfinder: Go to medfinder.com and enter your medication, dosage, and location. medfinder calls pharmacies near you to find which ones can fill your prescription, then texts you the results.

Refill early: Start looking for your refill when you have 10+ days of medication left. Don't wait until your inhaler is empty.

Try independent pharmacies: Independent and specialty pharmacies often use different wholesale suppliers and may have stock when chain pharmacies don't.

Ask about special orders: Many pharmacies can order Qvar RediHaler from their wholesaler in 1-3 business days if they currently don't have it in stock.

Consider mail-order: Mail-order pharmacies maintain larger inventory buffers and offer 90-day supplies, reducing how often you need to refill.

Talk to your doctor: If you cannot find Beclomethasone, ask your prescriber about therapeutic alternatives. Generic fluticasone propionate, budesonide, mometasone, and ciclesonide can all serve as ICS alternatives.

What About Cost? Can Price Be the Problem?

For some patients, the issue isn't finding Qvar — it's affording it. Without insurance, Qvar RediHaler retails for $306-$414 per inhaler (10.6g, 120 inhalations). That's over $3,600 per year at twice-daily use. Here are cost-reduction options:

GoodRx coupon: Reduces price to approximately $196-$264 at participating pharmacies

Teva Savings Card: For commercially insured patients — reduces copay to as low as $15/fill; valid for up to 25 fills; register at qvar.com

Teva Cares Foundation PAP: Free Qvar for uninsured/underinsured patients who meet income requirements

Bottom Line for Patients

Beclomethasone is not in a formal FDA shortage, but real-world availability is inconsistent. The key actions are: refill early, expand beyond your usual pharmacy, and use medfinder to find stock quickly. For detailed strategies, see our guide on how to find Beclomethasone in stock near you.